About Dr. Kumar

About Dr. Dilip Kumar — Top Cardiologist in Kolkata

“Advancing Heart Care with Compassion, Precision, and Innovation.” Director – Cardiology at Manipal Hospital, EM Bypass, Kolkata, with over 15 years of experience in interventional cardiology and electrophysiology.

Dr. Dilip Kumar — Director, Cardiology, Manipal Hospital, EM Bypass, Kolkata MBBS · MD (Medicine) · DM (Cardiology) · FACC · FRCP (Glasg.) · FSCAI · FESC · FICC · FHRS · Certified Cardiac Device Specialist (CCDS, HRS, USA)
Dr. Dilip Kumar, top cardiologist in Kolkata and Director of Cardiology at Manipal Hospital
15+ Years as Senior
Consultant Cardiologist
Who is Dr. Dilip Kumar

A Leading Interventional Cardiologist in Kolkata

Dr. Dilip Kumar is widely regarded as one of the top cardiologists in Kolkata, currently serving as Director – Cardiology at Manipal Hospital, EM Bypass. He holds MBBS, MD (Medicine) and DM (Cardiology) degrees, along with international fellowships including FACC, FRCP (Glasgow), FSCAI, FESC, FICC and FHRS, and is a Certified Cardiac Device Specialist (CCDS, HRS, USA).

Since January 2010 he has practiced as Senior Consultant Interventional Cardiologist at Medica Superspecialty Hospital, Kolkata, and as Director of Cardiac Cath Lab Services at the Medica Institute of Cardiac Science — building one of the largest experiences of cardiac device implantation in India and pioneering structural heart interventions across Eastern India.

Book a Consultation
Experience

Clinical Experience

Jan 2010 – Present

Senior Consultant Interventional Cardiologist

Medica Superspecialty Hospital, Kolkata — over 15 years of experience in interventional cardiology.

Concurrent

Director, Cardiac Cath Lab Services

Medica Institute of Cardiac Science — overseeing complex coronary and structural heart interventions.

Current

Director – Cardiology

Manipal Hospital, EM Bypass, Kolkata, and Care Now Multispeciality Polyclinic.

Fellowships

International Fellowships

Heart Rhythm Society, USA
Society of Cardiovascular Angiography & Interventions, USA
Royal College of Physicians (Glasg.)
European Society of Cardiology
Indian College of Cardiology
American College of Cardiology
Heart Failure Association
Professional Memberships

Professional Memberships

  • Fellow of the Society for Cardiovascular Angiography & Interventions (FSCAI)
  • Fellow of the European Society of Cardiology (FESC)
  • Fellow of the Heart Rhythm Society (FHRS)
  • Fellow of the American College of Cardiology (FACC)
  • Fellow of the Indian College of Cardiology (FICC)
  • Fellow of the Heart Failure Association (HFA)
Awards & Honours

Awards & Honours

  • One of the largest experiences of device implantations in India
  • Multiple publications in national and international journals
  • University Topper in DM Cardiology, WBUHS, 2007
  • Winner of the National Postgraduate Quiz at Varanasi 2003 (APICON)
  • Healthcare Pioneers of the East (2020) Award by Times Group (Feb 26, 2020)
  • Pioneer in Structural Heart Interventions in Eastern India
Research

Clinical Research

  • Principal Investigator in multiple clinical trials (IBIS, PRESCO, TUXEDO, and others)
  • Numerous peer-reviewed publications in leading cardiology journals
  • Principal Investigator, TUXEDO Study
  • Principal Investigator, LIFELEAV WACHT study (ongoing)
  • Heart Failure Registry (ongoing)
  • Principal Investigator, EVER MINE Stent Phase III trial
  • Principal Investigator, PEACH F trial
  • Co-Investigator, GLOBAL DECICATE Registry (ongoing)
  • Author of book chapters and yearbooks in cardiology
Publications

Selected Publications

Real-world, prospective, multi-center, randomized study on WhatsApp-based patient engagement post-PCI (E-monitor). Indian Heart Journal 76:S32, December 2024. DOI:10.1016/j.ihj.2024.11.069
Year Book of Cardiology 2024 – Hypertension.
TCT-196: Real-World, Prospective, Multicenter, Randomized Study on WhatsApp-Based Interactive Platform and Remote Nursing (E-Monitor) Post-PCI. Journal of the American College of Cardiology 84(18):B14, October 2024. DOI:10.1016/jacc.2024.09.232
Left Bundle Branch Pacing in a Patient with Dextroposed Heart: A Case Report. September 2024.
Clinical safety and performance of the world's thinnest-strut Evermine50 everolimus-eluting stent: a 24-month follow-up of the Evermine 50 EES-1 study. AsiaIntervention 10(3):195-202, September 2024. DOI:10.4244/AIJ-D-24-00009
Incidence of Coronary Artery Disease after Permanent Pacemaker Implantation: A Hospital-based Study from East India. Journal of Innovations in Cardiac Rhythm Management 15(6):5911-5916, June 2024. DOI:10.19102/icrm.2024.15065
Precious twins and a precarious heart: Treating severe mitral stenosis in a high-stakes twin pregnancy – a case report. June 2024. DOI:10.1016/ihjcvr.2024.06.005
Two-Stent Strategy for Bifurcation Lesions in Percutaneous Transluminal Coronary Angioplasty: Real-World Evidence. World Journal of Cardiovascular Diseases, January 2024. DOI:10.4236/wjcd.2024143012
Fenestration – Integrating Wings Into the Atrial Septal Occluder for Navigating a Challenging Terrain. Cureus 15(9), September 2023. DOI:10.7759/cureus.45260
Case Series: LOT-CRT in Patients with Refractory Heart Failure and Non-LBBB Morphology. September 2023. DOI:10.4103/HFJI.HFJI_46_23
Real World Evidence of Bempedoic Acid on Efficacy and Safety in Patients with Uncontrolled LDL-c and at High Risk of CVD. Cardiology and Angiology – An International Journal, June 2023. DOI:10.9734/ca/2023/v12i4350
Permanent Pacemakers and Defibrillators. May 2023.
Real World Evidence of Bempedoic Acid on Efficacy and Safety in Patients with Uncontrolled LDL-c and at High Risk of CVD. January 2023.
Clinical expert consensus document on the use of percutaneous left ventricular assist devices during complex high-risk PCI in India using a standardised algorithm. AsiaIntervention 8(2):75-85, October 2022.
Left Bundle Branch Pacing in a Scoliosis Patient with Symptomatic Brady-arrhythmia: A Case Report. International Journal of Science and Research (IJSR), Vol. 10, Issue 5, May 2021.
Long term clinical outcomes of thrombus aspiration in STEMI patients undergoing primary percutaneous coronary intervention. Am J Cardiovasc Dis 2020;10(2):117-123, June 2020.
Consensus and development of document for management of stabilized acute decompensated heart failure with reduced ejection fraction in India. Indian Heart Journal 72(2020) 477-481.
Procedural safety and outcome of ultrathin strut stent (<60µm) in the management of very long coronary artery stenosis (>30mm) – a retrospective real world study. Am J Cardiovasc Dis 2020;10(3):182-188.
Endovascular stent-graft repair of an asymptomatic large splenic artery aneurysm. IHJ Cardiovascular Case Reports 2020, 4(2); 65-67.
Strontium in atrioventricular conduction disorder: Is it a new target? J Indian Coll Cardiol 2020. DOI: 10.4103/jicc.jicc_82_20
Vision & Mission

Vision & Mission

Vision

To be a leading force in the field of interventional cardiology and electrophysiology, delivering world-class, innovative cardiac care that transforms lives and sets new standards of excellence in healthcare across India and beyond.

Mission

  • Provide comprehensive, patient-centered cardiovascular care using advanced technology and techniques, with a focus on safety, precision and compassion.
  • Lead the field in structural heart disease interventions and electrophysiology by continuously updating clinical practice with the latest research and innovations.
  • Educate and inspire the next generation of cardiologists through active academic involvement and mentorship.
  • Promote heart health awareness and preventive care, empowering individuals to take control of their cardiovascular well-being.

Consult Dr. Dilip Kumar

For appointments, call +91 91473 71208 or +91 99032 37563.

Contact Us